首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >TARGETING PEPT1 FOR DETECTING PANCREAS CANCER WITH [~11C]GLY-SAR: MICROPET IMAGING OF NUDE MICE BEARING ASPC-1, CAPAN-2, and MPANC-96 XENOGRAFTS
【24h】

TARGETING PEPT1 FOR DETECTING PANCREAS CANCER WITH [~11C]GLY-SAR: MICROPET IMAGING OF NUDE MICE BEARING ASPC-1, CAPAN-2, and MPANC-96 XENOGRAFTS

机译:靶向PEPT1检测[〜11C] Gly-SAR胰腺癌:携带ASPC-1,CAPAN-2和MPANC-96异种移植物的裸鼠的显微成像

获取原文
获取原文并翻译 | 示例
           

摘要

Background; Pancreatic cancer is a devastating disease, with over 30,00 patients affected in the USA in 2004 [1] and only a 3-5% two-year survival. Early detection and accurate staging are believed to be the only way to improve prognoses, yet diagnosis remains challenging. Many PET tracers have been used for imaging tumors by targeting specific features that discriminate tumor from normal cells [2], but none are very effective for pancreatic cancer. Recent studies reported amplification of peptide transporter PepTl in tumors, including human pancreatic cancer cell lines AsPC-1 and Capan-2 [3]. In normal tissue, PepTl and its homolog PepT2 transport di- and tri-peptides and many peptidomimetic drugs into cells. A radiotracer for PepTl could be useful for identification and staging of pancreatic cancer.
机译:背景;胰腺癌是一种毁灭性疾病,2004年美国有超过30,00例患者受到感染[1],两年生存率只有3-5%。早期检测和准确的分期被认为是改善预后的唯一方法,但诊断仍然具有挑战性。许多PET示踪剂已通过靶向特定特征将肿瘤与正常细胞区分开来[2],用于肿瘤成像,但没有一种对胰腺癌非常有效。最近的研究报道了包括人类胰腺癌细胞系AsPC-1和Capan-2在内的肿瘤中肽转运蛋白PepT1的扩增[3]。在正常组织中,PepT1及其同系物PepT2将二肽和三肽以及许多拟肽药物转运到细胞中。 PepT1的放射性示踪剂可用于胰腺癌的鉴定和分期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号